REGN
Price
$559.80
Change
+$4.67 (+0.84%)
Updated
Aug 7, 04:59 PM (EDT)
Capitalization
58.84B
84 days until earnings call
ROIV
Price
$11.55
Change
-$0.10 (-0.86%)
Updated
Aug 7, 04:59 PM (EDT)
Capitalization
7.95B
4 days until earnings call
Interact to see
Advertisement

REGN vs ROIV

Header iconREGN vs ROIV Comparison
Open Charts REGN vs ROIVBanner chart's image
Regeneron Pharmaceuticals
Price$559.80
Change+$4.67 (+0.84%)
Volume$5.2K
Capitalization58.84B
Roivant Sciences
Price$11.55
Change-$0.10 (-0.86%)
Volume$176.5K
Capitalization7.95B
REGN vs ROIV Comparison Chart in %
Loading...
REGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ROIV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
REGN vs. ROIV commentary
Aug 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is REGN is a Buy and ROIV is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 08, 2025
Stock price -- (REGN: $559.80 vs. ROIV: $11.55)
Brand notoriety: REGN: Notable vs. ROIV: Not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: REGN: 78% vs. ROIV: 80%
Market capitalization -- REGN: $58.84B vs. ROIV: $7.95B
REGN [@Biotechnology] is valued at $58.84B. ROIV’s [@Biotechnology] market capitalization is $7.95B. The market cap for tickers in the [@Biotechnology] industry ranges from $199.59B to $0. The average market capitalization across the [@Biotechnology] industry is $2.29B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

REGN’s FA Score shows that 1 FA rating(s) are green whileROIV’s FA Score has 0 green FA rating(s).

  • REGN’s FA Score: 1 green, 4 red.
  • ROIV’s FA Score: 0 green, 5 red.
According to our system of comparison, both REGN and ROIV are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

REGN’s TA Score shows that 5 TA indicator(s) are bullish while ROIV’s TA Score has 7 bullish TA indicator(s).

  • REGN’s TA Score: 5 bullish, 4 bearish.
  • ROIV’s TA Score: 7 bullish, 3 bearish.
According to our system of comparison, ROIV is a better buy in the short-term than REGN.

Price Growth

REGN (@Biotechnology) experienced а +2.63% price change this week, while ROIV (@Biotechnology) price change was +1.32% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.18%. For the same industry, the average monthly price growth was +8.39%, and the average quarterly price growth was +12.02%.

Reported Earning Dates

REGN is expected to report earnings on Oct 30, 2025.

ROIV is expected to report earnings on Aug 11, 2025.

Industries' Descriptions

@Biotechnology (+1.18% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
REGN($58.8B) has a higher market cap than ROIV($7.95B). REGN has higher P/E ratio than ROIV: REGN (13.99) vs ROIV (1.97). ROIV YTD gains are higher at: -1.522 vs. REGN (-21.853). REGN has higher annual earnings (EBITDA): 5.42B vs. ROIV (-1.1B). REGN has more cash in the bank: 7.47B vs. ROIV (4.89B). ROIV has less debt than REGN: ROIV (100M) vs REGN (2.71B). REGN has higher revenues than ROIV: REGN (14.2B) vs ROIV (29.1M).
REGNROIVREGN / ROIV
Capitalization58.8B7.95B740%
EBITDA5.42B-1.1B-493%
Gain YTD-21.853-1.5221,436%
P/E Ratio13.991.97712%
Revenue14.2B29.1M48,797%
Total Cash7.47B4.89B153%
Total Debt2.71B100M2,705%
FUNDAMENTALS RATINGS
REGN: Fundamental Ratings
REGN
OUTLOOK RATING
1..100
66
VALUATION
overvalued / fair valued / undervalued
1..100
4
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
54
PRICE GROWTH RATING
1..100
62
P/E GROWTH RATING
1..100
95
SEASONALITY SCORE
1..100
48

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
REGNROIV
RSI
ODDS (%)
Bearish Trend 2 days ago
44%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
72%
Bearish Trend 2 days ago
68%
Momentum
ODDS (%)
Bearish Trend 2 days ago
49%
Bullish Trend 2 days ago
62%
MACD
ODDS (%)
Bearish Trend 2 days ago
55%
Bullish Trend 2 days ago
67%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
64%
Bullish Trend 2 days ago
63%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
63%
Bullish Trend 2 days ago
63%
Advances
ODDS (%)
Bullish Trend 4 days ago
61%
Bullish Trend 2 days ago
70%
Declines
ODDS (%)
Bearish Trend 2 days ago
55%
Bearish Trend 7 days ago
72%
BollingerBands
ODDS (%)
Bearish Trend 7 days ago
56%
Bearish Trend 2 days ago
66%
Aroon
ODDS (%)
Bullish Trend 2 days ago
65%
Bullish Trend 3 days ago
67%
View a ticker or compare two or three
Interact to see
Advertisement
REGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ROIV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
MGMT41.110.52
+1.29%
Ballast Small/Mid Cap ETF
SKOR48.830.02
+0.05%
FlexShares Credit-Scored US Corp Bd ETF
LIAU227.34N/A
N/A
LifeX 2060 Infl-Prt Longevity Inc ETF
TCAF36.36-0.01
-0.03%
T. Rowe Price Capital Apprec Eq ETF
ZSL23.35-0.14
-0.60%
ProShares UltraShort Silver

REGN and

Correlation & Price change

A.I.dvisor indicates that over the last year, REGN has been loosely correlated with ROIV. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if REGN jumps, then ROIV could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To REGN
1D Price
Change %
REGN100%
-2.59%
ROIV - REGN
42%
Loosely correlated
+0.17%
IDYA - REGN
40%
Loosely correlated
-2.03%
KRYS - REGN
40%
Loosely correlated
-0.98%
ACLX - REGN
39%
Loosely correlated
-1.90%
TECH - REGN
38%
Loosely correlated
-8.73%
More

ROIV and

Correlation & Price change

A.I.dvisor indicates that over the last year, ROIV has been loosely correlated with ACLX. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if ROIV jumps, then ACLX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ROIV
1D Price
Change %
ROIV100%
+0.17%
ACLX - ROIV
53%
Loosely correlated
-1.90%
IMVT - ROIV
53%
Loosely correlated
-3.33%
CRNX - ROIV
52%
Loosely correlated
-2.43%
RNA - ROIV
50%
Loosely correlated
+26.14%
CGON - ROIV
50%
Loosely correlated
-6.12%
More